[1]
Zhao, B. , Luo, M. , Wang, A. and Zhang, W. 2022. MiR-182 antagonist alleviates glucocorticoid-induced secondary bone degeneration and osteoclast differentiation. Cellular and Molecular Biology. 67, 5 (Feb. 2022), 123–130. DOI:https://doi.org/10.14715/cmb/2021.67.5.17.